Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection. by Lewis RE, Klepser ME, Ernst EJ, Lund BC, Biedenbach DJ and Jones RN published in Antimicrob. Agents Chemother. 1999; 43 (8): 2005-2009